retatrutide 2025 trial results Retatrutide: What It Is & How This New Drug Works New Obesity Drug Helped People

However, the significant weight loss it promotes can lead to a temporary condition called telogen effluvium, which is responsible for most hair thinning users report

GLP-1 medications may activate key biological pathways that support longevity. Taking smaller (micro) doses may lower the risk of side effects, creating harmony with your bodys natural processes to support healthspan

Doctors and patients alike are increasingly exploring how fractional doses can target specific metabolic and inflammatory issues without the intensity of a full weight-loss regimen

Phase 2 results have been published in obesity (Jastreboff and colleagues, N Engl J Med, 2023) and in type 2 diabetes (Rosenstock and colleagues, Lancet, 2023), and the compound has since progressed into the phase 3 TRIUMPH programme

Waser, B., Beetschen, K., Pellegata, N

Medical Disclaimer: This article is for informational purposes only and not medical advice